FARALLON CAPITAL PARTNERS LP 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 4:28 pm Unchanged |
2024-12-31 | 13G | Elevation Oncology, Inc. ELEV |
FARALLON CAPITAL PARTNERS LP | 3,527,482 6.000% |
0 (Unchanged) |
Filing |
| 2024-11-08 11:54 am Purchase |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
FARALLON CAPITAL PARTNERS LP | 3,527,482 6.000% |
427,482 (+13.79%) |
Filing |
| 2024-01-22 09:02 am Purchase |
2024-01-12 | 13G | Elevation Oncology, Inc. ELEV |
FARALLON CAPITAL PARTNERS LP | 3,100,000 7.300% |
3,100,000 (New Position) |
Filing |